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Abstract
Introduction—Electronic cigarette (e-cigarette) use is increasing dramatically in developed 
countries, but little is known about these rapidly evolving products. This study analyzed and 
evaluated the chemical composition including nicotine, tobacco alkaloids, pH and flavors in 36 e-
liquids brands from four manufacturers.
Methods—We determined the concentrations of nicotine, alkaloids, and select flavors and 
measured pH in solutions used in e-cigarettes. E-cigarette products were chosen based upon 
favorable consumer approval ratings from online review websites. Quantitative analyses were 
performed using strict quality assurance/quality control (QC) validated methods previously 
established by our lab for the measurement of nicotine, alkaloids, pH and flavors.
Results—Three-quarters of the products contained lower measured nicotine levels than the stated 
label values (6% - 42% by concentration). The pH for e-liquids ranged from 5.1 – 9.1. Minor 
tobacco alkaloids were found in all samples containing nicotine, and their relative concentrations 
varied widely among manufacturers. A number of common flavor compounds were analyzed in all 
e-liquids.
Conclusions—Free nicotine levels calculated from the measurement of pH correlated with total 
nicotine content. The direct correlation between the total nicotine concentration and pH suggests 
that the alkalinity of nicotine drives the pH of e-cigarette solutions. A higher percentage of 
nicotine exists in the more absorbable free form as total nicotine concentration increases. A 
number of products contained tobacco alkaloids at concentrations that exceed U.S. Pharmacopeia 
limits for impurities in nicotine used in pharmaceutical and food products.
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Electronic cigarettes (e-cigarettes) or electronic nicotine delivery systems (ENDS) are 
rapidly gaining acceptance among consumers and becoming a lucrative product in the 
tobacco market.1,2 Recently, the CDC reported that e-cigarette use doubled from January 
2011 to January 2012 among teens.3 E-cigarettes are battery powered aerosol generating 
devices that use a resistive heating coil to vaporize a solution containing propylene glycol, 
glycerin, flavors, frequently nicotine and sometimes ethanol and water. The solution, also 
known as e-liquid or e-juice, is contained in a disposable or refillable cartridge depending on 
the design of the e-cigarette. Solutions for e-cigarettes are available in many flavors that 
most often fall in five main categories: tobacco flavors (which are similar to cigarettes), fruit 
flavors (blueberry, peach, etc.), menthol flavors, sweet flavors (candy, chocolate, etc.) and 
other flavors (coffee, black tea, wine, etc.). E-liquids are available in varying nicotine 
concentrations that typically range from 0 mg/mL to 24 mg/mL nicotine.4-7
The typical e-cigarette often resembles a traditional cigarette and consists of three main 
parts: a battery, a cartridge and an atomizer containing a heating coil, though more recent 
versions of e-cigarettes have combined the cartridge and atomizer. When a user draws on an 
e-cigarette, a pressure switch/sensor activates the heating element to vaporize the e-liquid, 
the vapor then rapidly condenses to form an aerosol. A growing number of e-cigarette 
designs are currently on the market and these appear to be rapidly evolving to help facilitate 
the delivery of nicotine to the consumer in a pleasing manner. In addition to the original e-
cigarette design, numerous new, larger versions, often referred to as tank systems are 
increasing in popularity. The tank e-cigarette devices are customizable and often bear no 
resemblance to a cigarette. They also usually have a manually activated switch that turns on 
the heating coil. Because the e-cigarette’s nicotine delivery is directly related to the power 
delivery (wattage) of the device, tank e-cigarettes may incorporate a voltage tunable 
battery.8 Users can then adjust or “tune” the voltage to deliver their differing amounts of 
nicotine. E-cigarettes have become highly customizable to meet the specific needs of users. 
Customizable features include replaceable heating coils with two or more wicks for better 
vaporization and multiple chamber atomizers that claim to produce a more “robust” vapor.9
Some manufacturers of e-cigarettes market the products as a safer alternative to combustible 
tobacco and in some cases imply that the products are free of harmful substances. While 
manufacturers do not promote e-cigarettes as cessation devices, they have been investigated 
for this purpose with mixed results. Some literature has shown that e-cigarettes have shown 
some promise as a potential cessation tool for smoking. 10 For example, a recent study from 
the United Kingdom found that when e-cigarettes were used as an aid for cessation, users 
were 60% more likely to sustain cessation when compared to conventional nicotine 
reduction therapies.11 Despite those results, a number of other studies have shown that e-
cigarette use was not associated with smoking cessation.1,12,13 In addition, a recent study 
among Korean adolescents showed that “adolescents who tried to quit smoking were more 
likely to use e-cigarettes but less likely to no longer smoke, which suggests that e-cigarettes 
inhibit rather than promote cessation.”14 Similar results were observed for US adolescents.15 
Consumers may perceive that e-cigarettes are a safe alternative to cigarettes, which could 
increase experimentation.16 However, the public health impact of using e-cigarettes cannot 
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be adequately assessed given the relatively limited and inconsistent data on e-cigarettes 
currently available.
In order to assess claims about the safety of e-cigarettes, more research needs to be done to 
further examine the chemical contents of e-liquids. There are limited analytical data on 
chemicals in e-cigarette cartridges and refill solutions. Nicotine is the most widely studied 
constituent. Deviation between labeled and measured concentrations of nicotine in refill 
solutions has been reported.17-26 The nicotine used in these devices is extracted from 
tobacco, and with it, other tobacco constituents are co-extracted. Other analytes of interest 
that have been tested in refill cartridges include tobacco-specific nitrosamines (TSNAs),27 
aldehydes,28 tobacco alkaloids18, 23, 25, 26 and flavors.21 The aim of this study was to 
provide further analysis of potentially harmful substances contained in e-cigarettes. In order 
to help address the existing information gap, we measured pH as well as the concentration of 
nicotine, tobacco alkaloids, and selected flavors found in the cartridges and refill solutions 
of 36 varieties of e-cigarettes using robust, quantitative, and validated methods.
METHODS
Samples
E-cigarette materials were purchased online directly from four manufacturers (eSmoke, 
www.eSmoke.net; Premium, www.premiumecigarette.com; V2, www.v2cigs.com; South 
Beach Smoke, www.southbeachsmoke.com). A total of 36 varieties (South Beach Smoke, 7 
samples; V2, 8 samples; Premium, 10 samples; eSmoke, 11 samples) were analyzed in this 
study. Brands were chosen based upon consumer approval ratings from online review 
websites (www.ecig-reviews.net, www.ecigcity.net) at the time of purchase. Upon receipt, 
samples were logged into a custom database, assigned barcodes with a unique barcoded ID, 
and stored in their original containers until analyzed. Samples in cartridge form were 
uncapped and the solution soaked contents were removed. The saturated reservoir material 
was compressed inside a 3-mL disposable syringe and the liquid was collected in a vial. 
Liquid refill samples were used as provided by the manufacturers. For each product, only 
one manufacturer lot was analyzed; thus lot-to-lot variability was not assessed.
Reagents and materials
Nicotine standards were purchased from AccuStandard (New Haven, Connecticut). 
Quinoline used as an internal standard for nicotine was purchased from Sigma-Aldrich (St. 
Louis, Missouri). Nicotiana glauca was purchased through Lab Depot (Dawsonville, 
Georgia). The pH calibration solutions were purchased from Control Company 
(Friendswood, Texas).
Alkaloid standards nornicotine, myosmine, anabasine, anatabine, and isonicoteine were 
purchased from Toronto Research Chemicals (Toronto, Ontario; Canada). Standards were 
purchased as racemic mixtures, if applicable. Isotopically labeled internal standard, (+/−) 
nornicotine-2,4,5,6-d4 (pyridine-d4), was purchased from CDN Isotopes (Pointe-Claire, 
Quebec, Canada); DL-Nicotine (methyl-d3) was obtained from Cambridge Isotope Labs 
(Andover, Massachusetts). These were added to samples and used for quantification.
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Flavor standards (eucalyptol, camphor, menthol, methyl salicylate, pulegone, ethyl 
salicylate, cinnamaldehyde, eugenol, diphenyl ether and coumarin) were purchased from 
Sigma-Aldrich (St. Louis, Missouri). 3’,4’-(methylenedioxy)-acetophenone (MDA) was also 
purchased from Sigma-Aldrich and was used as an internal standard for quantifying flavor 
analytes. Research cigarettes, 3R4F, were obtained from the University of Kentucky and 
were used as matrix blank for spiking calibration standards (Lexington, Kentucky). All other 
chemicals were of analytical grade and were purchased through Fisher Scientific unless 
otherwise indicated (Pittsburgh, Pennsylvania).
Sample Preparation and Analysis Procedures
Nicotine analysis was based on modifications to a previously reported method.29 
Modifications include the use of GC-MS/MS (rather than GC-MS) and a faster GC run time 
(2.3 minutes versus 3.7 minutes). Also, the sample size was adjusted from 1000 mg to 400 
mg, and the corresponding standard and extraction solvent volumes were scaled 
appropriately.
The sample preparation for the nicotine method used a 400 mg (±2 mg) sample size. 
Samples of e-juice were weighed into a 15 mL amber vial, spiked with 50 μL of quinoline 
internal standard (10.5 mg/mL), and 100 μL of alkaloids internal standard consisting of D3-
nicotine (0.38 mg/mL) and D4-nornicotine (0.41 mg/mL). A 1 mL aliquot of 2N NaOH was 
added, and the sample was allowed to stand at room temperature for 15 minutes. Afterwards, 
10 mL of methyl tert-butyl ether was added and the vials were capped and placed on a 
Rugged Rotator (Glass-Col, Terre Haute, Indiana) to tumble at 70 revolutions/minute for 1 
hour. After agitation, sample extracts were expressed through a 0.45 μM filter directly into 
individual GC vials. Samples were run in triplicate (N=3) and analyzed. The GC-MS/MS 
hardware setup is the same for both the nicotine and alkaloids and because the internal 
standard for alkaloids was also added, the same samples could be analyzed for minor 
tobacco alkaloids. The analysis of nicotine and minor alkaloids was performed using a 
separate injection and a separate method on the same instrument. Analysis was performed in 
triplicate (N=3). Nicotine concentrations were reported in mg/g rather than mg/mL because 
the exact ratio of propylene glycol/glycerin in each e-liquids was not known.
Triplicate (N=3) samples were prepared and analyzed for minor alkaloid concentrations 
using the methods previously outlined.30 Flavors analysis was also performed on triplicate 
samples (N=3) using methods previously outlined by Lisko et. al.31 The pH analyses were 
done using the method described in a Federal Register Notice,32 and samples were analyzed 
in duplicate (N=2).
Instrumentation and Apparatus
Flavors GC/MS analysis was performed using an Agilent 7890 GC coupled with a 5975 
MSD (Agilent Technologies; Newark, DE, USA). The chromatographic separation was 
accomplished using an Ultra-2 capillary column (25m × 0.32mm × 0.52μM) (Agilent 
Technologies; Andover, MA, USA) with research grade helium (>99.9999% purity) used as 
the carrier gas. Specific details of the previously validated method can be found in Lisko et. 
al.31
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Alkaloids GC-MS/MS analyses were performed using an Agilent 7890 GC coupled with a 
7000 Triple-Quad detector (Newark, DE). The chromatographic separation was 
accomplished using a DB-1701 capillary column (30m × 0.250 μM, 0.25 μM) (J&W 
Scientific) with research grade (>99.9999% purity) helium used as the carrier gas. Specific 
details of the previously validated method can be found in Lisko et. al.30
Nicotine GC-MS/MS analysis was performed using an Agilent 7890 GC coupled with a 
7000 Triple-Quad detector (Newark, DE) equipped with a CTC autosampler (Agilent 
Technologies; Andover, MA), which injects 1 μL of the extract per vial for analysis. The 
split/splitless injector was maintained at 230 °C with a helium flow rate of 1.7 ml/min for 3 
min. Injections were made with a split ratio of 300:1 with a solvent delay of 1.2 min. The 
chromatographic separation (Supplemental Figure 1) was accomplished using a DB-1701 
capillary column (30m × 0.250 μM, 0.25 μM) (J&W Scientific) with research grade 
(>99.9999% purity) helium as the carrier gas. The GC ramp conditions were as follows: 175 
°C for 0.1 min; ramp at 10 °C/min to 180 °C; and lastly ramp 75 °C/min to 240 °C. The total 
GC run time was 2.3 minutes and the transfer line temperature was set to 285 °C. 
Compounds were ionized using electron impact ionization (70eV) in positive mode and the 
ion source maintained at 280 °C. Mass measurements were made in Multiple Reaction Mode 
(MRM). The retention times and m/z transition values chosen for detection are provided in 
Supplemental Table 1.
Standard curves were constructed by the analysis of Nicotiana glauca matrix spiked with 
known amounts of nicotine. N. glauca is an anabasine-rich tobacco species that contains no 
nicotine, which makes it an ideal matrix for calibration. The calibration range for the 
nicotine method was 0.05 - 42 mg/g and the limit of detection (LOD) was found to be 0.05 
mg/g. The calculation of LOD was estimated as 3s0, where s0 is the estimate of the standard 
deviation at zero analyte concentration. The value of s0 was taken as the y-intercept of a 
linear regression of standard deviation versus concentration as specified by Taylor et al.40 
The method was validated by measuring the precision and accuracy of nicotine at three 
concentration levels. Precision/accuracy data were obtained by spiking five blank matrix 
samples at low, medium and high concentration levels of nicotine. A blank control was 
prepared by spiking five N. glauca matrix samples with internal standard only. The precision 
and accuracy of the method were found to be 3.1-3.4% RSD and 93.9 – 97.9% recovery, 
respectively. A matrix comparison between N. glauca and propylene glycol was also 
performed to ensure there were no matrix effects that should be considered when evaluating 
samples. Standard curves were injected in triplicate and the slopes and intercepts were 
compared. Slope differences less than 5% indicate an absence of matrix effects. A summary 
of the matrix comparison as well as the validation parameters can be found in Supplemental 
Table 2.
The pH analysis was performed on a Sirius Vinotrate (Sirius Analytical, East Sussex, 
England) according to the method outlined in the Federal Register.32 We dissolved 500 mg 
samples in 5 mL of distilled deionized water and determined an average pH measurement 
over a 1 hour period. Synthetic e-juice samples were prepared by dissolving a corresponding 
amount of commercially available nicotine (Sigma-Aldrich) in a 1:1 mixture of glycerin/
propylene glycol to reflect concentrations of nicotine similar to those found in commercially 
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available e-juice. Samples for pH analysis were run in duplicate (n=2). The percentage of 
nicotine in the freebase form was calculated using the Henderson-Hasselbach equation 
according to previously established methods.32
RESULTS
Nicotine and Minor Tobacco Alkaloids
In agreement with previous literature reports, we found the measured nicotine concentration 
was often significantly lower than the labeled nicotine concentrations in the refill solutions 
and e-liquid cartridges. Using the student t-test, we observed that the measured nicotine 
levels were statistically lower than the stated label values for all varieties from three of the 
four manufacturers (p < 0.03). Measured nicotine concentrations were 5.8% - 41.7% lower 
than the labeled nicotine values for South Beach Smoke, V2 and Premium manufacturers. 
Premium 6 mg/mL e-liquid products were the least accurately labeled product tested, with 
41.7% less nicotine in the liquid than specified on the product’s labeling. Only one 
manufacturer, eSmoke, had nicotine levels on their labeling that was not statistically 
different than measured nicotine levels. Labeled nicotine concentrations for eSmoke 
products were within 3.4% of the measured nicotine concentration (Figure 1).
Inconsistencies among the measured nicotine concentrations among different flavors with 
the same labeled nicotine concentration were most evident in V2 and Premium varieties. 
The V2 12mg Sahara and Peppermint flavors had measured nicotine concentrations of 11 
mg and 9.6 mg respectively. Similarly, Premium 24mg Tobacco and Peach flavors had 
measured concentrations that were quite different, 20.5 mg and 16.5 mg respectively. While 
other researchers23 found measureable levels of nicotine in e-liquids labeled as containing 
no nicotine, we did not find measureable levels of nicotine in 0 mg refills and cartridges for 
the varieties tested from these four e-cigarette providers (LOD = 0.048 mg/g).
Minor tobacco alkaloids, nornicotine, myosmine, anabasine, anatabine and isonicoteine were 
found in all e-liquids tested that also contained nicotine (Table 1). In traditional tobacco, 
there are direct correlations between nicotine and minor alkaloid concentrations.33 However, 
when examining the correlation of measured nicotine and minor alkaloids in e-liquids, the 
relationship was not as consistent. Because of the structural similarity of the minor tobacco 
alkaloids and nicotine, extracts from tobacco to obtain nicotine used in e-liquids likely 
contain differing concentrations of the minor alkaloids depending on purification or other 
manufacturing processes. This likely affects the relative concentrations of minor alkaloids 
with respect to nicotine.
Poor quality control is another explanation for the poor correlation between nicotine and 
minor alkaloids. Among the samples tested, a number of samples with similar measured 
nicotine concentrations had widely varying minor alkaloid concentrations. For example, V2 
18 mg Menthol flavor and V2 18 mg Red flavor had anatabine levels of 23 and 193 μg/g, 
respectively. Also, eSmoke 11 mg Minty Menthol flavor and 11 mg Morning Coffee flavor 
had myosmine levels of 62.7 and 15.1 μg/g, respectively. Potentially, these flavors may have 
been made with different lots of nicotine solution but without knowing the manufacturing 
process, it is impossible to determine the cause of the variation.
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The American e-Liquid Manufacturing Standards Association (AEMSA), an industry group 
with no regulatory authority, calls for the use of US Pharmacopeia Grade (USP) grade 
nicotine in their e-liquid products.41 USP specifications of nicotine purity allow for a 
maximum of 0.5% (5 mg/g) of a single impurity and 1.0% (10 mg/g) total impurities.42 For 
example, a product containing 15.0 mg/g of nicotine can have up to 75 μg/g of a single 
impurity and a maximum of 150 μg/g total impurities. For the products tested, the majority 
of products tested had impurities that did not exceed USP limits, however, total alkaloid 
concentrations found in eSmoke brand exceeded USP limits in all products (Table 1). The 
V2 Red 18 mg solution as well as Premium Pineapple 11 mg and Premium Peach 24 mg 
solutions each had a single impurity (anatabine) that exceeded USP limits. Total alkaloids 
for the V2 Red 18mg solution and the Premium Pineapple 11 mg solutions also exceed the 
proposed USP limits.
It is important to note, however, that when nicotine is exposed to air, oxidation can occur 
which results in the generation of minor alkaloids.43, 44 Because the rate of oxidation in e-
liquids has not been reported and the time between e-liquid production and testing is not 
known, it is difficult to assess the concentrations of alkaloids due to nicotine oxidation. 
Regardless of the source of alkaloids, whether the nicotine was exposed to air during 
manufacturing or an impure nicotine source was used, a number of samples were found to 
have alkaloid impurities that exceed USP specifications. While the health implications of 
select impurities are not known, we draw attention here to illustrate differences in the 
manufacturers approach to product design.
The minor tobacco alkaloid concentrations in e-liquids are generally much lower when 
compared to traditional cigarettes. Traditional cigarettes have minor tobacco alkaloid 
concentrations in the range of 659 – 986 μg/g for nornicotine, 8.6 – 17.3 μg/g for myosmine, 
127 – 185 μg/g for anabasine, 927 – 1390 μg/g for anatabine and 23.4 – 45.5 μg/g for 
isonicoteine.30 eSmoke e-liquids had the highest concentrations of the minor tobacco 
alkaloids (6.3 – 48.2 μg/g nornicotine, 8.7 – 62.7 μg/g myosmine, 21.2 – 152 μg/g anabasine, 
63.1 – 485 μg/g anatabine and 2.4 – 20.7 μg/g isonicoteine). South Beach Smoke, V2 and 
Premium products contained considerably less alkaloid content, suggesting a either a more 
pure nicotine extract was used or nicotine oxidation was minimized for those refill 
cartridges.
Flavors
We tested the 36 e-cigarette products for ten flavor compounds commonly used as additives 
in tobacco products. These compounds included eucalyptol, camphor, menthol, methyl 
salicylate, pulegone, ethyl salicylate, cinnamaldehyde, eugenol, diphenyl ether and coumarin 
(Table 2). Measureable levels of eucalyptol (<LOD – 87 μg/g) and pulegone (<LOD - 119 
μg/g) were found in the menthol flavored varieties for all manufacturers. Menthol 
concentrations ranged from 3700 – 12,000 μg/g in flavored e-liquids, which is similar to 
levels found in commercial cigarette filler.34, 35 Menthol and pulegone are typical flavors 
found in mint products as well. Interestingly, menthol was also found at low concentrations 
in 40% of the tobacco-flavored non-menthol products tested in this study. Tobacco Gold 
flavor (South Beach Smoke) as well as Sahara and Red flavors (V2) contained low 
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concentrations of menthol (6.2 -14.7 μg/g). Added menthol may reduce harshness or more 
closely simulate the sensory experience of smoking traditional cigarettes.
pH
The pH values for each e-liquid correlated with the measured total nicotine concentration 
(Table 3). In general, higher total nicotine concentrations yielded higher pH values due to 
inherent alkalinity of nicotine. To test this hypothesis, synthetic e-liquids were prepared 
using a 1:1 mixture of propylene glycol and glycerin to create e-liquids with nicotine 
concentrations of 6 mg/mL, 11 mg/mL, 18 mg/mL and 24 mg/mL. A series of pH 
measurements were made on the laboratory prepared e-liquids and a direct relation between 
total nicotine concentration and pH was observed. When testing the commercial brands of e-
liquid, a similar correlation between nicotine and pH exists. However, the commercial 
products contain a number of other flavor additives that could influence the resulting e-
liquid pH, thus creating a weaker nicotine/pH relationship in commercial products. Nicotine 
free e-liquids were slightly acidic (pH 5.1 – 6.4), possibly due to the absence of nicotine and 
the presence of weakly acidic substances.
The percentage of nicotine in the free (unprotonated) form can be calculated using the 
Henderson-Hasselbach equation based on measured pH and total nicotine.32 The free or 
unprotonated form of nicotine is more readily absorbed by the user than protonated forms, 
increasing the rate of uptake of nicotine received by the user.36 Generally, all e-liquids that 
contained nicotine had free-base nicotine concentrations in the range of 60-90%, and there 
was a trend toward increasing free-base nicotine concentrations as the measured total 
nicotine concentrations increased. Because it was determined that the pH is driven by the 
alkalinity of nicotine in laboratory prepared e-liquids, this observation was expected (Figure 
2). The correlation between pH, measured nicotine and free-base nicotine is not as strong 
(R2 = 0.827 for commercial products versus R2 = 0.965 for laboratory prepared e-liquids), 
likely due to flavors and other additives found in the various e-liquids. For the nicotine-
containing products tested, the free-base nicotine percentages plateaued at approximately 
90%.
DISCUSSION
We evaluated pH, nicotine, flavors and minor tobacco alkaloids in e-liquid found in 
cartridges and refill solutions of four e-cigarette manufacturers: South Beach Smoke, 
Premium, V2 and eSmoke. The measured nicotine levels for South Beach Smoke, Premium 
and V2 were all significantly lower than the labeled concentrations. Because labels are 
inaccurate, an inherent consumer risk exists in that consumers do not know how much 
nicotine they may be exposed to when using e-cigarettes. Although results from this study 
found measured nicotine levels lower than labeled concentrations, other studies have found 
more nicotine than labeled concentrations.17-26 Regardless of the inaccuracies on the label, 
most of the e-liquids tested had a high percentage (60 – 90%) of nicotine existing in free or 
unprotonated form. The amount of nicotine in e-liquids can result in adverse medical effects 
if ingested37 and as a result, calls to poison control centers about exposures to e-cigarette 
products have increased dramatically.38 Minor tobacco alkaloids were found in all nicotine 
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containing e-liquid varieties, which suggests the nicotine in the e-liquids is extracted from 
tobacco. In some cases, minor alkaloid levels indicate that the nicotine used in certain e-
liquids exceeded USP impurity specifications. The limitation of this observation is that the 
oxidation rate of nicotine is unknown, thus the source of impurities cannot be identified with 
certainty. Products from all four manufacturers tested contained measureable levels of 
flavors. Flavors have been shown to play an important role in helping enhance the 
experience for the e-cigarette user, as well as potentially aiding with smoking 
abstinence.45,46 Although flavored e-cigarette products are popular with adult users, sweet 
and candy-like flavors may make e-cigarettes attractive to children.39 The pH of e-liquids 
that were examined was largely driven by the concentration of nicotine due to its alkalinity. 
A direct correlation was found between pH, measured total nicotine concentration, and free 
nicotine (%) in e-liquids.
This research assessed single manufacturer lots of 36 different e-liquids from four 
manufacturers; much more research is needed to more fully characterize e-cigarettes and 
assess potential public health concerns resulting from increased use of e-cigarettes and other 
electronic nicotine delivery devices. Our evaluation of the e-liquids provides insight into 
constituents and additives in current brands, but given the number of brands and the 
dynamic market, and we believe routine analytical testing of products is warranted.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Measured nicotine concentrations were consistently lower than labeled amounts for all 
brands tested except eSmoke.
Lisko et al. Page 12














Comparison of measured nicotine and free base nicotine for commercial and synthetic e-
juice indicate nicotine’s alkalinity drives pH and the subsequent free-nicotine (%) levels. A 
logarithmic fit was chosen based on the characteristics of the Henderson-Hasselbach 
equation.
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Table 2
Concentrations (μg/g, N=3) of selected flavor analytes* in e-Cigarette cartridges or refill solutions.
Flavor Nicotine Label EUC CAM MEN PUL CINN ESAL
South Beach Smoke
Vanilla 0 mg - - - - - -
Tobacco 6 mg - - - - - -
Tobacco Blue 6 mg - - - - - -
Tobacco Gold 12 mg - 10.2 ± 2.1 6.2 ± 0.8 - - -
Peppermint 12 mg - - 3670 ± 161 25.7 ± 1.0 47.1 ± 0.9 -
Peach 16 mg - - - - - -
Menthol 16 mg 24.5 ±0.4 - 7780 ± 141 28.2 ± 0.4 - -
V2
Menthol 0 mg 21.6 ± 0.5 - 11200 ± 428 119 ± 3.8 - -
Menthol 18 mg 39.4 ± 0.8 - 11100 ± 246 50.1 ± 0.9 - -
Sahara 6 mg - - 14.7 ± 5.4 - - -
Sahara 12 mg - - 13.1 ± 1.8 - - -
Red 6 mg - - - - - -
Red 18 mg - - 13.6 ± 1.0 - - -
Peppermint 0 mg - 5.9 ± 0.4 9770 ± 307 78.3 ± 1.7 37.6 ± 0.2 -
Peppermint 12 mg - 5.8 ± 0.5 9530 ± 281 82.7 ± 1.9 10.4 ± 0.4 -
Premium
Cherry 0 mg - 1310 ± 75.3 - - - 13.0 ± 0.6
Coffee 0 mg - - - - - -
Watermelon 6 mg - - - - - -
Blueberry 6 mg - 278 ± 8.9 - - - -
Pineapple 11 mg - 13.3 ± 2.0 - - - -
Menthol 11 mg 86.8 ± 3.4 - 12400 ± 468 115 ± 2.8 98.6 ± 2.2 -
Pear 16 mg - - - - - -
Vanilla 16 mg - - - - - -
Tobacco 24 mg - - - - - -
Peach 24 mg - - - - - -
eSmoke
Morning Coffee 0 mg - - - - - -
Morning Coffee 6 mg - - - - - -
Morning Coffee 11 mg - - - - - -
Morning Coffee 16 mg - - - - - -
Red El Toro 6 mg - - - - - -
Green Apple 6 mg - - - - - -
Tobacco 11 mg - - - - - -
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Flavor Nicotine Label EUC CAM MEN PUL CINN ESAL
Minty Menthol 11 mg 20.3 ± 0.7 - 4860 ± 150 10.5 ± 0.6 - -
Caribbean Coconut 11 mg - - - - - -
MTN Mist 16 mg - 9.9 ± 1.6 - - - -
Red El Toro 24 mg - - - - - -
EUC: Eucalyptol, CAM: Camphor, MEN: Menthol, PUL: Pulegone, CINN: Cinnamaldehyde, ESAL: Ethyl Salicylate
- Denotes < LOD.
*
All e-Cigarette samples were also tested for Diphenyl Ether, Coumarin, Methyl Salicylate and Eugenol but these flavor analytes were not 
detected.
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Table 3











Vanilla 0 <LOD NA 5.3 NA
Tobacco 6 4.5 −25.0 8.3 65.9
Tobacco Blue 6 4.2 −30.0 7.9 44.4
Tobacco Gold 12 9.7 −19.2 8.4 68.8
Peppermint 12 9.2 −23.3 8.7 81.9
Menthol 16 13.1 −18.1 8.5 77.0
Peach 16 12.2 −23.8 8.8 86.3
V2
Menthol 0 <LOD NA 6.4 NA
Sahara 6 5.4 −10.0 7.8 38.7
Red 6 5.9 −1.7 8.4 69.7
Sahara 12 11 −8.3 8.5 76.6
Peppermint 12 9.6 −20.0 8.2 62.5
Menthol 18 15.3 −15.0 8.7 83.8
Red 18 16.7 −7.2 8.9 87.1
Premium
Cherry 0 <LOD NA 5.3 NA
Coffee 0 <LOD NA 5.8 NA
Blueberry 6 3.7 −38.3 7.3 14.7
Watermelon 6 3.3 −45.0 7.7 32.9
Pineapple 11 6.9 −37.3 8.0 48.5
Menthol 11 8.5 −22.7 8.8 85.1
Pear 16 10.1 −36.9 8.2 59.6
Vanilla 16 13.9 −13.1 8.4 69.5
Tobacco 24 20.5 −14.6 8.9 89.3
Peach 24 16.5 −31.3 8.4 71.7
eSmoke
Morning Coffee 0 <LOD NA 5.1 NA
Red El Toro 6 6.0 0.0 8.5 76.9
Morning Coffee 6 6.1 1.7 8.4 71.6
Green Apple 6 6.2 3.3 8.6 79.8
Tobacco RY4 11 11.3 2.7 8.8 86.1
Minty Menthol 11 10.4 −5.5 8.5 75.8
Caribbean Coconut 11 11.1 0.9 8.8 86.9























Morning Coffee 11 11.2 1.8 8.7 82.5
Morning Coffee 16 16.5 3.1 8.9 87.4
MTN Mist 16 16.6 3.8 9.1 91.7
Laboratory-prepared e-juice
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